Prospects and limitations of post-transplantation alloantibody detection in renal transplantation

Human Immunology

Volumn 70, Issue 8, 2009, Pages 640-644

  Böhmig, Georg A ^a   Bartel, Gregor ^a   Regele, Heinz ^a   Wahrmann, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Alloantibody; C4d; HLA; Monitoring; Renal transplantation

Indexed keywords

ALLOANTIBODY; COMPLEMENT COMPONENT C4D;

ALLOIMMUNITY; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; FLOW CYTOMETRY; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; IMMUNOASSAY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ANTIBODY FORMATION; BIOPSY; EPITOPES; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSORBENT TECHNIQUES; ISOANTIBODIES; KIDNEY; KIDNEY TRANSPLANTATION; MONITORING, PHYSIOLOGIC; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 68049121859     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.04.014     Document Type: Article

References (63)

1. Terasaki P.I. Humoral theory of transplantation. Am J Transplant 3 (2003) 665-673
2. Colvin R.B. Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 18 (2007) 1046-1056
3. Feucht H.E., and Mihatsch M.J. Diagnostic value of C4d in renal biopsies. Curr Opin Nephrol Hypertens 14 (2005) 592-598
4. Racusen L.C., Colvin R.B., Solez K., Mihatsch M.J., Halloran P.F., Campbell P.M., et al. Antibody-mediated rejection criteria -an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3 (2003) 708-714
5. Solez K., Colvin R.B., Racusen L.C., Sis B., Halloran P.F., Birk P.E., et al. Banff '05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 7 (2007) 518-526
6. Solez K., Colvin R.B., Racusen L.C., Haas M., Sis B., Mengel M., et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 8 (2008) 753-760
7. Mauiyyedi S., Crespo M., Collins A.B., Schneeberger E.E., Pascual M.A., Saidman S.L., et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 13 (2002) 779-787
8. Böhmig G.A., Exner M., Habicht A., Schillinger M., Lang U., Kletzmayr J., et al. Capillary C4d deposition in kidney allografts: A specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 13 (2002) 1091-1099
9. Scornik J.C., Guerra G., Schold J.D., Srinivas T.R., Dragun D., and Meier-Kriesche H.U. Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunction. Am J Transplant 7 (2007) 1808-1814
10. Worthington J.E., McEwen A., McWilliam L.J., Picton M.L., and Martin S. Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome. Transplantation 83 (2007) 398-403
11. Uehara S., Chase C.M., Cornell L.D., Madsen J.C., Russell P.S., and Colvin R.B. Chronic cardiac transplant arteriopathy in mice: Relationship of alloantibody, C4d deposition and neointimal fibrosis. Am J Transplant 7 (2007) 57-65
12. Minami K., Murata K., Lee C.-Y., Fox-Talbot K., Wasowska B.A., Pescovitz M.D., et al. C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats. Am J Transplant 6 (2006) 923-932
13. Qian Z., Lee C.Y., Murata K., Liu J., Fox-Talbot K., Wasowska B.A., et al. Antibody and complement mediated injury in transplants following sensitization by allogeneic blood transfusion. Transplantation 82 (2006) 857-864
14. Venetz J.P., and Pascual M. New treatments for acute humoral rejection of kidney allografts. Expert Opin Investig Drugs 16 (2007) 625-633
15. Böhmig G.A., Wahrmann M., Regele H., Exner M., Robl B., Derfler K., et al. Immunoadsorption in severe C4d-positive acute kidney allograft rejection: A randomized controlled trial. Am J Transplant 7 (2007) 117-121
16. Perry D.K., Burns J.M., Pollinger H.S., Amiot B.P., Gloor J.M., Gores G.J., et al. Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production. Am J Transplant 9 (2009) 201-209
17. Theruvath T.P., Saidman S.L., Mauiyyedi S., Delmonico F.L., Williams W.W., Tolkoff-Rubin N., et al. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation 72 (2001) 77-83
18. Schwarz C., Regele H., Huttary N., Wahrmann M., Exner M., Nagy-Bojarsky K., et al. Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy. Wien Klin Wochenschr 118 (2006) 397-404
19. Billing H., Rieger S., Ovens J., Susal C., Melk A., Waldherr R., et al. Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients. Transplantation 86 (2008) 1214-1221
20. Kao K.J., Scornik J.C., and Small S.J. Enzyme-linked immunoassay for anti-HLA antibodies-an alternative to panel studies by lymphocytotoxicity. Transplantation 55 (1993) 192-196
21. Kerman R.H., Susskind B., Buelow R., Regan J., Pouletty P., Williams J., et al. Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection. Transplantation 62 (1996) 201-205
22. Pei R., Wang G., Tarsitani C., Rojo S., Chen T., Takemura S., et al. Simultaneous HLA Class I and Class II antibodies screening with flow cytometry. Hum Immunol 59 (1998) 313-322
23. Pei R., Lee J.H., Shih N.J., Chen M., and Terasaki P.I. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 75 (2003) 43-49
24. El-Awar N., Lee J., and Terasaki P.I. HLA antibody identification with single antigen beads compared with conventional methods. Hum Immunol 66 (2005) 989-997
25. Bielmann D., Honger G., Lutz D., Mihatsch M.J., Steiger J., and Schaub S. Pretransplant risk assessment in renal allograft recipients using virtual crossmatching. Am J Transplant 7 (2007) 626-632
26. Süsal C., and Opelz G. Options for immunologic support of renal transplantation through the HLA and immunology laboratories. Am J Transplant 7 (2007) 1450-1456
27. Lefaucheur C., Suberbielle-Boissel C., Hill G.S., Nochy D., Andrade J., Antoine C., et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant 8 (2008) 324-331
28. Zachary A.A., and Leffell M.S. Detecting and monitoring human leukocyte antigen-specific antibodies. Hum Immunol 69 (2008) 591-604
29. Vaidya S., Partlow D., Susskind B., Noor M., Barnes T., and Gugliuzza K. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead Luminex assay. Transplantation 82 (2006) 1524-1528
30. Billen E.V., Voorter C.E., Christiaans M.H., and van den Berg-Loonen E.M. Luminex donor-specific crossmatches. Tissue Antigens 71 (2008) 507-513
31. Zou Y., Stastny P., Susal C., Dohler B., and Opelz G. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 357 (2007) 1293-1300
32. Schaub S., and Scornik J.C. High-tech detection of HLA antibodies and complement: Prospects and limitations. Am J Transplant 8 (2008) 5-6
33. Wahrmann M., Exner M., Regele H., Derfler K., Körmöczi G.F., Lhotta K., et al. Flow cytometry based detection of HLA alloantibody mediated classical complement activation. J Immunol Methods 275 (2003) 149-160
34. Smith J.D., Hamour I.M., Banner N.R., and Rose M.L. C4d fixing, Luminex binding antibodies-a new tool for prediction of graft failure after heart transplantation. Am J Transplant 7 (2007) 2809-2815
35. Bartel G., Wahrmann M., Exner M., Regele H., Huttary N., Schillinger M., et al. In vitro detection of C4d-fixing HLA alloantibodies: Associations with capillary C4d deposition in kidney allografts. Am J Transplant 8 (2008) 41-49
36. Mizutani K., Terasaki P., Hamdani E., Esquenazi V., Rosen A., Miller J., et al. The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients. Am J Transplant 7 (2007) 1027-1031
37. Alvarez-Marquez A., Aguilera I., Gentil M.A., Caro J.L., Bernal G., Fernandez Alonso J., et al. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies. Transplantation 87 (2009) 94-99
38. Bartel G., Regele H., Wahrmann M., Huttary N., Exner M., Hörl W.H., et al. Posttransplant HLA alloreactivity in stable kidney transplant recipients-incidences and impact on long-term allograft outcomes. Am J Transplant 8 (2008) 2652-2660
39. Böhmig G.A., Bartel G., and Wahrmann M. Antibodies, isotypes and complement in allograft rejection. Curr Opin Organ Transplant 13 (2008) 411-418
40. Martin L., Guignier F., Mousson C., Rageot D., Justrabo E., and Rifle G. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplantation 76 (2003) 395-400
41. Heinemann F.M., Roth I., Rebmann V., Arnold M.L., Witzke O., Wilde B., et al. Immunoglobulin isotype-specific characterization of anti-human leukocyte antigen antibodies eluted from explanted renal allografts. Hum Immunol 68 (2007) 500-506
42. Suberbielle C., Legendre C., Chkoff N., Meunier D., Kreis H., Charron D., et al. Anti-HLA sensitization after renal transplant excision: A retrospective study in 84 patients. Transplant Proc 28 (1996) 2814
43. Adeyi O.A., Girnita A.L., Howe J., Marrari M., Awadalla Y., Askar M., et al. Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. Transpl Immunol 14 (2005) 53-62
44. Billen E.V., Christiaans M.H., Lee J., and van den Berg-Loonen E.M. Donor-directed HLA antibodies before and after transplantectomy detected by the Luminex single antigen assay. Transplantation 87 (2009) 563-569
45. McKenna R.M., Takemoto S.K., and Terasaki P.I. Anti-HLA antibodies after solid organ transplantation. Transplantation 69 (2000) 319-326
46. Piazza A., Poggi E., Borrelli L., Servetti S., Monaco P.I., Buonomo O., et al. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: Posttransplant analysis using flow cytometric techniques. Transplantation 71 (2001) 1106-1112
47. Lee P.C., Terasaki P.I., Takemoto S.K., Lee P.H., Hung C.J., Chen Y.L., et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 74 (2002) 1192-1194
48. Terasaki P.I., and Ozawa M. Predicting kidney graft failure by HLA antibodies: A prospective trial. Am J Transplant 4 (2004) 438-443
49. Mizutani K., Terasaki P., Rosen A., Esquenazi V., Miller J., Shih R.N., et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 5 (2005) 2265-2272
50. Smith R.N., Kawai T., Boskovic S., Nadazdin O., Sachs D.H., Cosimi A.B., et al. Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys. Am J Transplant 8 (2008) 1662-1672
51. Terasaki P.I., and Ozawa M. Predictive value of HLA antibodies and serum creatinine in chronic rejection: Results of a 2-year prospective trial. Transplantation 80 (2005) 1194-1197
52. Fiebeler A., Mengel M., Merkel S., Haller H., and Schwarz A. Diffuse C4d deposition and morphology of acute humoral rejection in a stable renal allograft. Transplantation 76 (2003) 1132-1133
53. Mengel M., Bogers J., Bosmans J.L., Seron D., Moreso F., Carrera M., et al. Incidence of C4d stain in protocol biopsies from renal allografts: Results from a multicenter trial. Am J Transplant 5 (2005) 1050-1056
54. Yoon H.E., Kim S.H., Kim J.Y., Oh E.J., Park S.C., Choi B.S., et al. Clinical significance of C4d deposition in stable renal allografts in the early post-transplantation period. Clin Transplant (2008) Epub ahead of print
55. Burns J.M., Cornell L.D., Perry D.K., Pollinger H.S., Gloor J.M., Kremers W.K., et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant 8 (2008) 2684-2694
56. Platt J.L. C4d and the fate of organ allografts. J Am Soc Nephrol 13 (2002) 2417-2419
57. Haas M., Rahman M.H., Racusen L.C., Kraus E.S., Bagnasco S.M., Segev D.L., et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: Correlation with histologic findings. Am J Transplant 6 (2006) 1829-1840
58. Haas M., Segev D.L., Racusen L.C., Bagnasco S.M., Locke J.E., Warren D.S., et al. C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J Am Soc Nephrol 20 (2009) 197-204
59. Bach F.H., Ferran C., Hechenleitner P., Mark W., Koyamada N., Miyatake T., et al. Accommodation of vascularized xenografts: Expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 3 (1997) 196-204
60. Delikouras A., Hayes M., Malde P., Lechler R.I., and Dorling A. Nitric oxide-mediated expression of Bcl-2 and Bcl-xl and protection from tumor necrosis factor-alpha-mediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody. Transplantation 71 (2001) 599-605
61. Salama A.D., Delikouras A., Pusey C.D., Cook H.T., Bhangal G., Lechler R.I., et al. Transplant accommodation in highly sensitized patients: A potential role for Bcl-xL and alloantibody. Am J Transplant 1 (2001) 260-269
62. Grubbs B.C., Benson B.A., and Dalmasso A.P. Characteristics of CD59 up-regulation induced in porcine endothelial cells by alphaGal ligation and its association with protection from complement. Xenotransplantation 10 (2003) 387-397
63. Tang A.H., and Platt J.L. Accommodation of grafts: Implications for health and disease. Hum Immunol 68 (2007) 645-651